Last reviewed · How we verify

NCT07244211: FASTER-HIP

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Recruiting now NA Last updated 6 April 2026
What this trial tests

NA trial testing Hip arthroplasty in Femoral Neck Fractures in 600 participants. Currently enrolling.

Timeline
23 January 2026
Primary endpoint
28 February 2029
31 January 2030

Quick facts

Lead sponsorUniversity of Southern California
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment600
Start date23 January 2026
Primary completion28 February 2029
Estimated completion31 January 2030
Sites6 locations across Canada, United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

60 and older, any sex, with Femoral Neck Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old. We hypothesize that arthroplasty will reduce death, preserve ambulation, increase days alive and out of hospital, and improve health status compared to internal fixation within 4 months and 12 months from randomization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hip arthroplasty

Trials testing the same drug.

Other recruiting trials for Femoral Neck Fractures

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07244211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing